Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiregion, Randomized, Controlled, Blinded Study of the Safety and Efficacy of Bone Healing Accelerant Versus Standard of Care in Subjects With Open Tibia Fractures

NCT04056429 is registered in ClinicalTrials.gov with Carmell Therapeutics Corporation as lead sponsor.

NCT NCT04056429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04056429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiregion, Randomized, Controlled, Blinded Study of the Safety and Efficacy of Bone Healing Accelerant Versus Standard of Care in Subjects With Open Tibia Fractures
Lead sponsor
Carmell Therapeutics Corporation
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2026
Completion date
September 30, 2028
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tibial fractures